Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. Mustafa Naz\u0131m Karalezli, kas iskelet sistemi t\u00fcm\u00f6rlerini anlatt\u0131. Kemik t\u00fcm\u00f6rlerinin \u00e7e\u015fitlerini, bulgular\u0131n\u0131 ve tedavi se\u00e7eneklerini payla\u015fan Dr. Karalezli, \u00f6zellikle gen\u00e7lerde diz ve omuz \u00e7evresi a\u011fr\u0131lar\u0131na vurgu yaparak “10-20 ya\u015f aras\u0131ndaki gen\u00e7lerde diz ve omuz a\u011fr\u0131s\u0131 \u00f6nemlidir” ifadelerini kulland\u0131.
\n
Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. Mustafa Naz\u0131m Karalezli, kas-iskelet sistemi t\u00fcm\u00f6rlerine ili\u015fkin \u00f6nemli de\u011ferlendirmelerde bulundu.
\n
Kemir t\u00fcm\u00f6rleri
\n
T\u00fcm\u00f6rlerin her zaman k\u00f6t\u00fc huylu olmad\u0131\u011f\u0131na dikkat \u00e7eken Karalezli, “Kemik t\u00fcm\u00f6rleri kabaca ikiye ayr\u0131l\u0131r. \u0130yi huylu t\u00fcm\u00f6rler ve k\u00f6t\u00fc huylu t\u00fcm\u00f6rler yani kanserler” ifadelerini kullanarak, k\u00f6t\u00fc huylu t\u00fcm\u00f6rlerin hem kemi\u011fin kendi kanserlerinden hem de v\u00fccudun ba\u015fka yerlerinden s\u0131\u00e7rayan t\u00fcm\u00f6rlerden kaynaklanabilece\u011fini s\u00f6yledi. Kemik t\u00fcm\u00f6rleri aras\u0131nda en s\u0131k metastatik t\u00fcm\u00f6rlerin g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktaran Karalezli, “Asl\u0131nda en \u00e7ok g\u00f6r\u00fclen kemik t\u00fcm\u00f6rleri metastatik t\u00fcm\u00f6rlerdir. Yani v\u00fccutta herhangi bir yerdeki t\u00fcm\u00f6r\u00fcn kemi\u011fe s\u0131\u00e7ramas\u0131 ile olan t\u00fcm\u00f6rlerdir. Kemi\u011fe en \u00e7ok metastaz yapan kanserler akci\u011fer, meme, b\u00f6brek, troid ve prostat kanserleridir” dedi.
\n
Belirtilerin hastal\u0131\u011f\u0131n t\u00fcr\u00fcne g\u00f6re de\u011fi\u015fti\u011fini belirten Prof. Dr. Karalezli, “Metastatik t\u00fcm\u00f6rlerin bulgular\u0131 as\u0131l t\u00fcm\u00f6r\u00fcn oldu\u011fu yere g\u00f6re de\u011fi\u015fir. \u00d6rne\u011fin akci\u011fer kanserinin bulgusu ile b\u00f6brek kanserininki farkl\u0131d\u0131r. Ama genel olarak halsizlik, bulant\u0131, kilo kayb\u0131 ve ate\u015f gibi bulgular g\u00f6r\u00fclebilir. Metastatik t\u00fcm\u00f6rlerde ve kemi\u011fin kendi t\u00fcm\u00f6r\u00fcnde as\u0131l semptom a\u011fr\u0131d\u0131r” dedi.
\n
“A\u011fr\u0131 v\u00fccudun savunma ve uyar\u0131 mekanizmas\u0131d\u0131r”
\n
A\u011fr\u0131lar\u0131n \u00f6zelliklerine dikkat \u00e7eken Karalezli, “A\u011fr\u0131n\u0131n dinlenme s\u0131ras\u0131nda ve gece a\u011fr\u0131lar\u0131 \u015feklinde olmas\u0131 \u00f6nemlidir” diyerek ge\u00e7meyen kemik a\u011fr\u0131lar\u0131n\u0131n ihmal edilmemesi gerekti\u011fini vurgulad\u0131. Karalezli, “A\u011fr\u0131 v\u00fccudun savunma ve uyar\u0131 mekanizmas\u0131d\u0131r” ifadeleriyle uzun s\u00fcren, gittik\u00e7e artan ve ila\u00e7lara yan\u0131t vermeyen a\u011fr\u0131lar\u0131n ara\u015ft\u0131r\u0131lmas\u0131 gerekti\u011fini belirtti.
\n
“Metastatik t\u00fcm\u00f6rleri 50 ya\u015ftan sonra g\u00f6r\u00fcl\u00fcr”
\n
Ya\u015f gruplar\u0131na g\u00f6re risk da\u011f\u0131l\u0131m\u0131na da de\u011finen Karalezli, “\u0130statistiksel olarak primer kemik t\u00fcm\u00f6rleri en \u00e7ok 10-20 ya\u015f aras\u0131nda, metastatik t\u00fcm\u00f6rleri de 50 ya\u015ftan sonra g\u00f6r\u00fcl\u00fcrler” dedi. T\u00fcm\u00f6rlerin en s\u0131k g\u00f6r\u00fcld\u00fc\u011f\u00fc b\u00f6lgelerin de ya\u015fa g\u00f6re de\u011fi\u015fti\u011fini s\u00f6yleyerek, “En \u00e7ok diz \u00e7evresi. Daha sonra omuz \u00e7evresi. Metastatik t\u00fcm\u00f6rler ise omurga ve kal\u00e7a \u00e7evresinde s\u0131kt\u0131r” ifadelerini kulland\u0131.
\n
“Kesin tan\u0131 ise biyopsi ile konulur”
\n
Tan\u0131da kan testlerinin s\u0131n\u0131rl\u0131 oldu\u011funu belirten Karalezli, “Genel olarak spesifik bir test yoktur. Kemik t\u00fcm\u00f6rlerinde g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleri daha \u00e7ok i\u015fe yararlar” diyerek r\u00f6ntgen, tomografi, MR ve sintigrafinin en \u00e7ok kullan\u0131lan y\u00f6ntemler oldu\u011funu s\u00f6yledi. “Kesin tan\u0131 ise biyopsi ile konulur” diye ekledi.
\n
Tedavi se\u00e7eneklerine ili\u015fkin konu\u015fan Karalezli, “Kemik t\u00fcm\u00f6rlerinde bazen hi\u00e7bir \u015fey yapmay\u0131z ve takip ederiz. Tabii ki bu iyi huylu oldu\u011fu kesin olan t\u00fcm\u00f6rlerde uygulanan bir y\u00f6ntemdir” dedi. \u0130yi huylu olsa bile baz\u0131 durumlarda cerrahiye ihtiya\u00e7 duyulabilece\u011fini belirterek, “K\u0131r\u0131k riski varsa, sinire bask\u0131 yap\u0131yorsa veya kemikte deformiteye neden oluyorsa iyi huylu da olsa cerrahi tedavi \u00f6neririz” ifadelerini kulland\u0131.
\n
K\u00f6t\u00fc huylu t\u00fcm\u00f6rlerde cerrahinin temel tedavi oldu\u011funu belirten Karalezli, “Cerrahi tedavide t\u00fcm\u00f6r\u00fc \u00e7\u0131kartabildi\u011fimiz gibi amp\u00fctasyon dedi\u011fimiz kolu veya baca\u011f\u0131 alma \u015feklinde \u00e7ok istemedi\u011fimiz tedavi \u015feklini de yapabiliriz” dedi. Son y\u0131llarda uzvu koruyucu y\u00f6ntemlerin geli\u015fti\u011fini vurgulad\u0131 ve baz\u0131 durumlarda kemoterapi ile cerrahinin birlikte uyguland\u0131\u011f\u0131n\u0131 s\u00f6yledi.
\n
Karalezli, patolojik k\u0131r\u0131klara ili\u015fkin olarak, “Normalde kemi\u011fin k\u0131r\u0131lmas\u0131na neden olmayacak enerjideki bir travma ile kemikte k\u0131r\u0131k olmas\u0131 patolojik k\u0131r\u0131kt\u0131r” diyerek bunun ekseriyetle kemik erimesi veya t\u00fcm\u00f6r gibi altta yatan nedenlerden kaynakland\u0131\u011f\u0131n\u0131 ifade etti.
\n
Toplumda yayg\u0131n olan yanl\u0131\u015f inan\u0131\u015flara da de\u011finen Karalezli, “T\u00fcm\u00f6re ne\u015fter vurulursa azar”, ” Bu \u00e7ok genel ve yanl\u0131\u015f bir inan\u0131\u015ft\u0131r” s\u00f6zleriyle cerrahiden ka\u00e7\u0131nman\u0131n do\u011fru olmad\u0131\u011f\u0131n\u0131 belirtti. Yanl\u0131\u015f tedavi edilen k\u00f6t\u00fc huylu t\u00fcm\u00f6rlerin tekrar edebilece\u011fini s\u00f6yleyerek, “Bu nedenle hastalar\u0131n da patoloji sonu\u00e7lar\u0131n\u0131 takip etmeleri gerekli ve \u00f6nemlidir” ifadelerini kulland\u0131.
<\/p>\n","protected":false},"excerpt":{"rendered":"
Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. Mustafa Naz\u0131m Karalezli, kas iskelet sistemi t\u00fcm\u00f6rlerini anlatt\u0131. Kemik t\u00fcm\u00f6rlerinin \u00e7e\u015fitlerini, bulgular\u0131n\u0131 ve tedavi se\u00e7eneklerini payla\u015fan Dr. Karalezli, \u00f6zellikle gen\u00e7lerde diz ve omuz \u00e7evresi a\u011fr\u0131lar\u0131na vurgu yaparak “10-20 ya\u015f aras\u0131ndaki gen\u00e7lerde diz ve omuz a\u011fr\u0131s\u0131 \u00f6nemlidir” ifadelerini kulland\u0131. Ortopedi ve Travmatoloji Uzman\u0131 Prof. Dr. Mustafa Naz\u0131m Karalezli, kas-iskelet sistemi…<\/p>\n","protected":false},"author":1,"featured_media":73287,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-73286","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/73286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=73286"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/73286\/revisions"}],"predecessor-version":[{"id":73288,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/73286\/revisions\/73288"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/73287"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=73286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=73286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=73286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}